Zelira Therapeutics Limited ZLDAF
0.01 USD 0.00 (-11.00%)
At closeNov 2, 2026, 4:00 PM EST
0.01 Day range 0.01
0.0089 52-week range 0.4165
- YTD
- -96.72%
- 1 year
- -96.00%
- Market cap
- 117.01K
- EPS (ttm)
- -0.20
- YTD return
- -96.72%
- 1-year return
- -96.00%
- Volume
- 200
- Avg volume
- 13
- Open
- 0.01
- Previous close
- 0.01
- Day's range
- 0.01 – 0.01
- 52-week range
- 0.0089 – 0.4165
2Y -0.4088 (-97.87%)
News
Zelira Therapeutics (OTCMKTS:ZLDAF) and Hyperion DeFi (NASDAQ:HYPD) Critical Analysis 
Zelira secures transformative US$33 million funding for HOPE® 1 autism program 
Zelira Therapeutics (OTCMKTS:ZLDAF) Trading Up 13.9% – Here’s Why 
Zelira Therapeutics (OTCMKTS:ZLDAF) Trading Down 4.4% – Here’s What Happened 
Zelira Therapeutics well placed to generate further growth in cash flow as commercialisation accelerates 
Zelira Therapeutics receives A$1.292 million cash R&D tax incentive 
Zelira Therapeutics receives 25% of US$1 million licensing fee from DRCN Holdings for EDCDM technology 
Zelira Therapeutics' Phase 1 dose escalation study in chronic pain patients on long-term opioid treatment published in peer-reviewed journal 
Zelira Therapeutics expands into growing New Zealand cannabinoid-based medicines market 
Zelira Therapeutics gets ethics green light for Phase 2a trial of sports injury cannabinoid
Your note
Sign in to keep a note on ZLDAF — it syncs with the Stock Master app.